The Landmark Series: Hilar cholangiocarcinoma Review

  


Authors: Soares, K. C.; Jarnagin, W. R.
Review Title: The Landmark Series: Hilar cholangiocarcinoma
Abstract: Hilar cholangiocarcinoma (HC) is a rare and highly aggressive biliary tract neoplasm. As such, the data driving the management of this disease generally are not based on prospective clinical trial data but rather consist of retrospective experiences and limited level 1 data. Surgical resection offers the best chance of a long-term survival, but local and distant recurrences are common. This report presents landmark articles that form the basis of preoperative, operative, and adjuvant strategies for HC. © 2021, Society of Surgical Oncology.
Journal Title: Annals of Surgical Oncology
Volume: 28
Issue: 8
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2021-08-01
Start Page: 4158
End Page: 4170
Language: English
DOI: 10.1245/s10434-021-09871-6
PUBMED: 33829358
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103927590&doi=10.1245%2fs10434-021-09871-6&partnerID=40&md5=156f510c32f4040a14f327a6ac390ff4
Notes: Review -- Export Date: 2 August 2021 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. William R Jarnagin
    903 Jarnagin
  2. Kevin Cerqueira Soares
    135 Soares
Related MSK Work